Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Wehling

Showing results (1-10 of 164) with videos related to

Pageof 17
Sort By:
Clinical Therapeutics|August 5, 2004
Can the pharmacokinetic characteristics of olmesartan medoxomil contribute to the improvement of blood pressure control?Martin Wehling
Nature Reviews. Drug Discovery|June 23, 2009
Assessing the translatability of drug projects: what needs to be scored to predict success?Martin Wehling
Journal of the American Medical Directors Association|March 21, 2013
Morbus diureticus in the elderly: epidemic overuse of a widely applied group of drugsMartin Wehling
Drug Discovery Today|August 9, 2011
Drug development in the light of translational science: shine or shade?Martin Wehling
Drug Research|November 16, 2019
Martin Wehling
Steroids|November 23, 2013
The history of RRSH meetings (Rapid responses to steroid hormones)Martin Wehling
Journal of Translational Medicine|June 19, 2008
Translational medicine: science or wishful thinking?Martin Wehling
Cardiology|March 2, 2012
Who protects physicians and patients from guidelines?Martin Wehling
Journal of the American Medical Directors Association|October 21, 2016
Older People, a Plethora of Drugs, and Drug List Approaches: Useful, Efficacious, or a Waste of Time?Martin Wehling
Zeitschrift Fur Gerontologie Und Geriatrie|September 24, 2017
[Drug therapy for older people : Choosing wisely]Martin Wehling
Pageof 17

Showing results (1-10 of 164) with videos related to

Sort By:
Pageof 17
Clinical Therapeutics|August 5, 2004
Can the pharmacokinetic characteristics of olmesartan medoxomil contribute to the improvement of blood pressure control?Martin Wehling
Nature Reviews. Drug Discovery|June 23, 2009
Assessing the translatability of drug projects: what needs to be scored to predict success?Martin Wehling
Journal of the American Medical Directors Association|March 21, 2013
Morbus diureticus in the elderly: epidemic overuse of a widely applied group of drugsMartin Wehling
Drug Discovery Today|August 9, 2011
Drug development in the light of translational science: shine or shade?Martin Wehling
Drug Research|November 16, 2019
Martin Wehling
Steroids|November 23, 2013
The history of RRSH meetings (Rapid responses to steroid hormones)Martin Wehling
Journal of Translational Medicine|June 19, 2008
Translational medicine: science or wishful thinking?Martin Wehling
Cardiology|March 2, 2012
Who protects physicians and patients from guidelines?Martin Wehling
Journal of the American Medical Directors Association|October 21, 2016
Older People, a Plethora of Drugs, and Drug List Approaches: Useful, Efficacious, or a Waste of Time?Martin Wehling
Zeitschrift Fur Gerontologie Und Geriatrie|September 24, 2017
[Drug therapy for older people : Choosing wisely]Martin Wehling
Pageof 17